A股異動丨幸福藍海漲逾5% 上影推影院抗疫紓困基金
格隆匯3月11日丨幸福藍海(300528.SZ)漲逾5%,報7.3元,總市值27.2億元。3月9日,上海電影集團宣佈推出全國首隻“影院抗疫紓困基金”,總額達10億元。據悉,上海電影集團、上海電影(601595)、上海精文投資有限公司共同成立全國首隻10億元“影院抗疫紓困基金”。目前,首批2億元資金已經到位。值得注意的是,該基金重點聚焦整個長三角地區有紓困需求的影院。幸福藍海主要從事電視劇業務和電影業務。其中,電影業務包括兩個子業務:電影投資、製作與發行;院線與影城經營。電視劇業務形成的產品是電視劇作品.
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.